• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WALLAC OY, SUBSIDIARY OF PERKINELMER SPECIMEN GATE LABORATORY; CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WALLAC OY, SUBSIDIARY OF PERKINELMER SPECIMEN GATE LABORATORY; CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE Back to Search Results
Model Number 5002-0180
Device Problems Computer Software Problem (1112); False Negative Result (1225); Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems Neonatal Deformities (1974); No Known Impact Or Consequence To Patient (2692); No Information (3190)
Event Date 09/22/2019
Event Type  malfunction  
Manufacturer Narrative
Correction of the configurable settings related to lsd assay result calculation was implemented on (b)(6) 2020.
 
Event Description
The (b)(6) department of health newborn screening (nbs) laboratory uses specimen gate laboratory (sgl) software during the analysis of specimens.Sgl contains a database and possesses functionality which enables laboratories to track specimens as they navigate through the laboratory with audit trails, security, and handling logic based on customer rules for qc, result-to-reference range analysis, result flagging, etc.When sgl software is installed, configurable settings are programmed based on the procedural workflow of the laboratory and the customer preferences.One of the assays that is run by the laboratory as part of the (b)(6) defined disorder panel is lysosomal storage disorders (lsd).The activity levels of gaa; galc; and idua present in dried blood spot specimens are used as markers to aid in screening newborns for the lysosomal storage disorders pompe, krabbe, and mps-1, respectively.A decreased activity is indicative of the disorder.On (b)(6) 2020 the customer reported to perkinelmer that the quality control flagging and result calculation was not working as expected concerning the lsd assay.Investigations revealed an error in the configurable settings of the lsd assay.Due to this error result blank subtraction was not done as part of result calculation by the sgl as intended.The calculated results were incorrectly high as the average of blanks on each plate was not subtracted from control and sample activities to get the final reportable results for gaa, galc, and idua.An agreed change had been implemented to the configurable settings for lsd assay on (b)(6) 2019 and the calculation error was unintentionally introduced to the settings during the implementation of the change.The settings were corrected to perform blank subtraction as part of the result calculation on (b)(6) 2020.The reported lsd results between (b)(6) 2019 and (b)(6) 2020, were reviewed to identify all specimens that were incorrectly reported as normal instead of with elevated risk.Specimens with elevated risk for any of the lysosomal storage disorders should have either undergone repeat testing (confirmation) per (b)(6) testing algorithm (for positive initial test) or undergone follow-up consisting of genetic consultation and diagnostic testing (for positive confirmation test).Altogether 14 affected specimens were found in the review, 11 specimens had incorrect results in initial test and 3 specimens had incorrect result in confirmation test.Repeat testing (confirmation) was performed for affected 11 specimens that should have been positive in initial test.Confirmation test results were within normal limits for all 11 specimens.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECIMEN GATE LABORATORY
Type of Device
CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE
Manufacturer (Section D)
WALLAC OY, SUBSIDIARY OF PERKINELMER
mustionkatu 6
turku, 20750
FI  20750
Manufacturer (Section G)
WALLAC OY, SUBSIDIARY OF PERKINELMER
mustionkatu 6
turku, 20750
FI   20750
Manufacturer Contact
rina wahlroos
mustionkatu 6
turku, FI-20-750
FI   FI-20750
MDR Report Key9673899
MDR Text Key221573151
Report Number8043909-2020-00001
Device Sequence Number1
Product Code JQP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Remedial Action Modification/Adjustment
Type of Report Initial
Report Date 01/02/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/05/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number5002-0180
Device Catalogue Number5002-0180
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/02/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/04/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-